SCIENTURE to Present at The Small Cap Showcase & WTR Insights on June 9, 2026, in NYC
Scienture (NASDAQ:SCNX) announced that its executive team will present at The Small Cap Showcase & WTR Insights in New York City on June 9, 2026 at 1:30 p.m. ET.
Rhea-AI Summary
Scienture (NASDAQ:SCNX) announced that its executive team will present at The Small Cap Showcase & WTR Insights in New York City on June 9, 2026 at 1:30 p.m. ET.
The event features a live webcast, replay access, and one-on-one investor meetings.
Positive
- None.
Negative
- None.
Details
News Market Reaction – SCNX
In the Jun 4 session, SCNX gained 0.03%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Conference date
- June 9, 2026
- The Small Cap Showcase & WTR Insights event date in New York City
- Presentation time
- 1:30 p.m. ET
- Scheduled time for Scienture’s corporate presentation at the event
- Participating companies
- approximately 20 companies
- Number of micro and small cap companies at The Small Cap Showcase & WTR Insights
Historical Context
-
U.S. patent granted for REZENOPY 10 mg nasal spray with protection to 2041.
-
Reported early revenue growth and margin expansion alongside a wider net loss.
-
Secured $11.0 million in non-dilutive debt to fund approved products and R&D.
-
Third U.S. patent for ARBLI oral suspension extending protection to October 2041.
-
Nasdaq granted 180-day extension to regain $1.00 bid price compliance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
nasdaq financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
COMMACK, NY / ACCESS Newswire / June 4, 2026 / SCIENTURE HOLDINGS, INC. (NASDAQ:SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through the development, commercialization, and distribution of novel specialty products that address unmet market needs, today announced that members of its executive management team will participate in The Small Cap Showcase & WTR Insights, taking place on June 9, 2026, in New York City.
Narasimhan Mani, President, co-CEO and Interim CFO of Scienture, will deliver a corporate presentation at 1:30 p.m. ET. A live webcast of the Company's presentation will be available at: https://www.webcaster5.com/Webcast/Page/3167/54112. A replay of the presentation will be available following the event and may also be accessed through the Company's website under the Investor Relations section.
Narasimhan Mani, Shankar Hariharan, Executive Chairman and co-CEO, and Rahul Surana, COO, will participate in one-on-one meetings with pre-qualified investors throughout the day.
The Small Cap Showcase & WTR Insights brings together executive management teams from approximately 20 micro and small cap companies across a diverse range of industries. This event provides a unique forum for discovering differentiated investment opportunities through company presentations, one on one meetings, industry insights, and networking opportunities.
For more information about The Small Cap Showcase & WTR Insights, please visit www.smallcapshowcase.com.
About Scienture Holdings, Inc.
SCIENTURE HOLDINGS, INC. (NASDAQ: "SCNX"), through its wholly owned subsidiary, Scienture, LLC, is a comprehensive pharmaceutical product company focused on providing enhanced value to patients, physicians and caregivers by offering novel specialty products to satisfy unmet market needs. Scienture, LLC is a branded, specialty pharmaceutical company consisting of a highly experienced team of industry professionals who are passionate about developing and bringing to market unique specialty products that provide enhanced value to patients and healthcare systems. The assets in development at Scienture are across therapeutics areas, indications and cater to different market segments and channels. For more information please visit www.scientureholdings.com and www.scienture.com.
CONTACT:
SCIENTURE HOLDINGS, INC.
20 Austin Blvd
Commack, NY 11725
Phone: (866) 468-6535
Email: IR@Scienture.com
SOURCE: Scienture Holdings, Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.